In O
human O
proliferative O
cells O
, O
the O
NADP O
- O
dependent O
ME B
activity O
is O
poorly O
expressed O
and O
barely O
inducible O
by O
thyroid O
hormones O
. O

3 O
' O
RNA O
boundary O
experiments O
indicate O
that O
the O
5 O
' O
structure O
reduces O
the O
number O
of O
( O
G O
/ O
U O
) O
AG O
repeats O
required O
for O
stable O
TRAP B
- O
trp B
leader O
RNA O
association O
. O

These O
exons O
, O
further O
identified O
as O
exons O
9 O
, O
10 O
, O
and O
11 O
, O
together O
encode O
the O
37 O
amino O
acid O
residues O
present O
in O
alpha B
s1 I
- I
casein I
variant I
A I
but O
missing O
in O
variant O
F O
. O

Intron O
- O
exon O
structure O
of O
the O
porcine B
I I
kappa I
B I
alpha I
- I
encoding I
gene I
. O

We O
propose O
that O
two O
pathways O
regulate O
Stat5 B
serine O
phosphorylation O
, O
one O
that O
is O
prolactin B
- O
activated O
and O
PD98059 O
- O
resistant O
and O
one O
that O
is O
constitutively O
active O
and O
PD98059 O
- O
sensitive O
and O
preferentially O
targets O
Stat5a B
. O

Another O
mutant O
, O
T255A O
, O
lost O
the O
ability O
to O
bind O
E4orf6 B
, O
but O
unexpectedly O
, O
viral O
late O
- O
gene O
expression O
was O
not O
affected O
. O

Using O
this O
method O
, O
we O
were O
able O
to O
select O
strong O
enhancer O
- O
type O
activation O
domains O
from O
the O
immediate B
early I
regions I
of O
two O
herpesviruses O
, O
namely O
pseudorabies O
virus O
and O
bovine O
herpesvirus O
1 O
. O

Inhibition O
of O
the O
Raf B
- I
1 I
kinase I
by O
cyclic O
AMP O
agonists O
causes O
apoptosis O
of O
v B
- I
abl I
- O
transformed O
cells O
. O

Removal O
of O
beta B
2 I
- I
microglobulin I
by O
hemodialysis O
and O
hemofiltration O
: O
a O
four O
year O
follow O
up O
. O

They O
share O
many O
downstream O
targets O
, O
including O
remodeling O
of O
the O
actin B
cytoskeleton O
, O
activation O
of O
p70 B
( I
S6 I
) I
kinase I
and O
c B
- I
jun I
N I
- I
terminal I
kinase I
( O
JNK B
) O
, O
and O
regulation O
of O
transcription O
and O
cell O
proliferation O
. O

Excision O
repair O
at O
the O
level O
of O
the O
nucleotide O
in O
the O
Saccharomyces B
cerevisiae I
MFA2 I
gene I
: O
mapping O
of O
where O
enhanced O
repair O
in O
the O
transcribed O
strand O
begins O
or O
ends O
and O
identification O
of O
only O
a O
partial O
rad16 B
requisite O
for O
repairing O
upstream O
control O
sequences O
. O

20 O
% O
of O
total O
HSL B
transcripts I
in O
human O
subcutaneous O
adipocytes O
. O

